Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 3.36 CHF 0.3% Market Closed
Updated: May 29, 2024

Molecular Partners AG
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Molecular Partners AG
Income from Continuing Operations Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
IDIA

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Income from Continuing Operations
-CHf84.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Income from Continuing Operations
-$234.5m
CAGR 3-Years
2%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Income from Continuing Operations
-CHf54.2m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Income from Continuing Operations
-$217.1m
CAGR 3-Years
18%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Income from Continuing Operations
CHf10.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Income from Continuing Operations
-CHf297.9m
CAGR 3-Years
13%
CAGR 5-Years
5%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Income from Continuing Operations?
Income from Continuing Operations
-84.7m CHF

Based on the financial report for Mar 31, 2024, Molecular Partners AG's Income from Continuing Operations amounts to -84.7m CHF.